Shares of Aarti Drugs Ltd. hit a 52-week high surging more than 16% on Monday on a share buyback proposal and a jump in its first-quarter profit.
Show more
Shares of the company surged 16.24% to Rs 593.45 apiece compared to a 0.18% decline in the Nifty 50 as of 12:30 p.m. on Monday.
The total traded quantity so far in the day stood at 23.7 times the 30-day average volume. The stock's relative strength index stands at 81, indicating that it may be overbought.
Of the three analysts tracking the stock, two maintain a 'buy' and one recommends a 'hold', according to Bloomberg data. The consensus price estimate indicates a 13.4% downside over the next 12 months.
WRITTEN BY
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
Infosys Buyback: IT Giant's Rs 18,000-Crore Share Repurchase Signals Long-Term Confidence, Say Analysts
Sep 12, 2025
Infosys Share Buyback: Stock Swings Higher Over Record Rs 18,000-Crore Share Repurchase
Sep 12, 2025
Infosys Buyback: US SEC Gives Exemptive Relief For Record Rs 18,000 Crore Share Repurchase
Sep 12, 2025
Infosys Announces First Share Buyback In Three Years — Check Details
Sep 11, 2025
POPULAR
1
Stock Market LIVE: GIFT Nifty Hints At Flat Open; Biocon, Texmaco Rail, Vedanta Shares In Focus
2
Renowned Tamil Actor And Comedian Robo Shankar Dies At 46
3
54 Dividend Stocks: BEML, Bajaj Holdings, Paisalo Digital — Last Day To Buy Shares To Qualify
4
Nvidia To Invest £2 Billion In UK Firms Including Wayve, Revolut
5